Your browser doesn't support javascript.
loading
A clinical study to monitor prescription patterns, clinical outcomes, and adverse drug reactions among patients of various interstitial lung diseases attending respiratory medicine outpatient department at tertiary care hospital in Northern India.
Hasan, Sabahat; Verma, Ajay; Haque, Shoebul; Asif, Farah; Nath, Rajendra; Kant, Surya; Dixit, Rakesh K.
Afiliación
  • Hasan S; Department of Pharmacology and Therapeutics, King Georges Medical University, Lucknow, Uttar Pradesh, India.
  • Verma A; Department of Respiratory Medicine, King Georges Medical University, Lucknow, Uttar Pradesh, India.
  • Haque S; Department of Pharmacology and Therapeutics, King Georges Medical University, Lucknow, Uttar Pradesh, India.
  • Asif F; Department of Pharmacology and Therapeutics, King Georges Medical University, Lucknow, Uttar Pradesh, India.
  • Nath R; Department of Pharmacology and Therapeutics, King Georges Medical University, Lucknow, Uttar Pradesh, India.
  • Kant S; Department of Respiratory Medicine, King Georges Medical University, Lucknow, Uttar Pradesh, India.
  • Dixit RK; Department of Pharmacology and Therapeutics, King Georges Medical University, Lucknow, Uttar Pradesh, India.
Perspect Clin Res ; 15(3): 141-146, 2024.
Article en En | MEDLINE | ID: mdl-39140017
ABSTRACT

Aim:

The aim of this study was to monitor prescription patterns, clinical outcomes, and adverse drug reactions (ADR) among patients of various interstitial lung diseases (ILDs). Materials and

Methods:

This prospective study was conducted in the Department of Pharmacology and Therapeutics in collaboration with the Department of Respiratory Medicine, King George's Medical University, Lucknow, for a period of 12 months (October 2020-September 2021). A total of 77 patients were enrolled after satisfying the inclusion and exclusion criteria. The prescriptions were collected, and necessary details were noted on the case report form. After completion of the study, the data were analyzed for prescription patterns, clinical outcomes, and quality of life with the help of a validated questionnaire-King's Brief ILD (KBILD) questionnaire. At the same time, ADRs, if any, were assessed using Hartwig's Severity Assessment Scale and Naranjo Causality Assessment Scale.

Results:

The most common ILD was acute/chronic hypersensitivity pneumonitis (HP). Average number of drugs per encounter was 4.45. Crepitations were the most common clinical signs. Clubbing and rhonchi were reported maximum in idiopathic pulmonary fibrosis. It was found that psychological, breathlessness and activities, chest symptoms, and total KBILD reduced significantly after 3 months as compared to baseline with a statistically significant difference as P < 0.01. ADRs were found in 23.38% (18) of the subjects. Maximum ADR reported was gastritis (9.09%), followed by hepatitis (3.90%).

Conclusion:

The high proportion of patients clinically diagnosed with HP in our study highlights the importance of a detailed environmental exposure history in the diagnostic evaluation of patients with ILD to avoid inaccurate diagnoses. ADR-related hospital admissions are a significant problem in the health-care system.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Perspect Clin Res Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Perspect Clin Res Año: 2024 Tipo del documento: Article